Maraviroc-containing HIV PrEP regimens safe, well toleratedhealthmedicinetAugust 23, 2017news Journal reference: Annals of Internal Medicine Related posts: HMN 2025: What is the new workflow to study HIV-1 genome-containing capsids HMN 2025: How Phase I trial finds topical PXS-6302 generally well tolerated in established skin scars Previous Post Study: Contact in Sports May Lead to Differences in the Brains of Young, Healthy Athletes Next Post Lab-made "mini organs" helping doctors treat cystic fibrosis
